Back to search
Primary Hyperoxaluria Type 3
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Hyperoxaluria Type 3 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Hyperoxaluria Type 3 trials you may qualify forThe purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria…
This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent…
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpo…
The aim of this study is to evaluate nedosiran in participants 11 years of age and younger who have Primary Hyperoxaluria with relatively intact renal function.
This randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy regimen with or…